IRCCS Ospedale San Raffaele

Running trials

• Not yet recruiting

  Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies

  NCT07759661· Source

• Not yet recruiting

  A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer

  NCT07610083· Source

• Not yet recruiting

  EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer

  NCT07803770· Source

• Not yet recruiting

  Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis

  NCT07571525· Source

• Not yet recruiting

  Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT

  NCT07544277· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

  NCT07587242· Phase 3· Source

• Not yet recruiting

  Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables

  NCT07533084· Source

• Not yet recruiting

  ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy

  NCT07597642· Source

• Recruiting

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· Phase 3· Source

• Active, not recruiting

  The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

  NCT07796776· Source

• Not yet recruiting

  M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials

  NCT07670143· Source

• Not yet recruiting

  A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

  NCT07455422· Source

• Recruiting

  Multicenter Study for External Validation of the TB-NET Score

  NCT07903532· Source

• Recruiting

  Evaluating Adherence to Guideline-Directed Medical Therapy in Patients With Advanced Heart Failure

  NCT07560982· Source

• Recruiting

  ATLG Levels in Autologous HSCT for Multiple Sclerosis

  NCT07635693· Source

• Recruiting

  Ultrasound Measurement of Thyroid Volume in Term Newborns

  NCT07579988· Source

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Source

• Recruiting

  A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06769698· Phase 2· Source

• Not yet recruiting

  Spinal Cord Stimulation Combined With Motor Training in Non-Traumatic SCI: A Prospective Interventional Study

  NCT07412808· Source

• Not yet recruiting

  Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients

  NCT07465458· Source

• Not yet recruiting

  Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease

  NCT07431255· Source

• Recruiting

  TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.

  NCT06887413· Source

• Recruiting

  A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07210723· Phase 2/3· Source

• Enrolling by invitation

  Autoimmune Hyperthyroidism in Prepubertal Children

  NCT07544290· Source

• Not yet recruiting

  Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

  NCT07265895· Source

• Recruiting

  Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

  NCT07330245· Source

• Recruiting

  Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL

  NCT07774390· Source

• Active, not recruiting

  Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL

  NCT07393204· Source

• Recruiting

  Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP).

  NCT07278921· Source

• Recruiting

  A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  NCT07213674· Phase 3· Source

• Recruiting

  A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma

  NCT07069751· Source

• Recruiting

  Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

  NCT07302321· Source

• Recruiting

  Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

  NCT06868927· Source

• Recruiting

  Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy

  NCT07095621· Source

• Recruiting

  A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

  NCT06523374· Source

• Recruiting

  Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC

  NCT07356544· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Source

• Recruiting

  Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen

  NCT07061379· Source

• Recruiting

  Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

  NCT06950385· Phase 3· Source

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Source

• Recruiting

  Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

  NCT06994377· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Source

• Not yet recruiting

  Institution of an Italian Multicenter Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database)

  NCT06790251· Source

• Recruiting

  Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study

  NCT06896305· Source

• Recruiting

  Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance

  NCT06866041· Source

• Active, not recruiting

  Physical Activity-based Intervention in Depressed Patients: Clinical, Neurophysiological, Epigenetic and Metabolic Correlates

  NCT06989944· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Source

• Recruiting

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· Phase 3· Source

• Recruiting

  A Prospective Observational Study of Artificial Intelligence Morphometric Evaluation of Vertebral Fractures

  NCT06449742· Source

• Recruiting

  Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation

  NCT06516341· Source

Showing 50 of 102.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Kidney cancer6 recruiting
• Bladder cancer5 recruiting
• Chronic lymphocytic leukaemia5 recruiting
• Heart failure5 recruiting
• Prostate cancer5 recruiting
• Crohn's disease4 recruiting
• Gastric and oesophageal cancer4 recruiting
• Lung cancer4 recruiting
• Alzheimer disease3 recruiting
• Childhood cancers3 recruiting
• Liver and biliary tract cancer3 recruiting
• Pancreatic cancer3 recruiting
• Acute myeloid leukaemia2 recruiting
• Barrett's oesophagus2 recruiting
• Coronary artery disease2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Dilated cardiomyopathy2 recruiting
• Follicular lymphoma2 recruiting
• Head and neck cancer2 recruiting
• High blood pressure2 recruiting
• Metastatic breast cancer2 recruiting
• Neuroendocrine tumours2 recruiting
• Ulcerative colitis2 recruiting
• ALS (motor neurone disease)1 recruiting
• ANCA-associated vasculitis1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Dystonia1 recruiting
• Frontotemporal dementia1 recruiting
• Graves' disease and hyperthyroidism1 recruiting
• Hypothyroidism1 recruiting
• Lupus (SLE)1 recruiting
• Mantle cell lymphoma1 recruiting
• Multiple myeloma1 recruiting
• Multiple sclerosis1 recruiting
• Myasthenia gravis1 recruiting
• Myocarditis1 recruiting
• Obesity1 recruiting
• Osteoporosis1 recruiting
• Ovarian cancer1 recruiting
• Polycystic kidney disease1 recruiting
• Retinitis pigmentosa1 recruiting
• Sarcoma1 recruiting
• Spinal cord injury1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 1 diabetes1 recruiting
• Ventricular tachycardia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  NCT06570798· Phase 2· Source

• Completed

  The Impact of Attentive System on Sleep Reactivity

  NCT06694818· Source

• Completed

  Semi-automatic Measurement of Renal Volume at CT Angiography to Plan Repair of Aortic Aneurysms in Patients With Horseshoe Kidney.

  NCT06749782· Source

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· Source

• Completed

  Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

  NCT06182085· Phase 2· Source

• Completed

  Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

  NCT06195150· Source

• Completed

  A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung).

  NCT06196424· Source

• Completed

  AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease

  NCT05471245· Source

• Completed

  Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury

  NCT05926843· Source

• Withdrawn

  Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients

  NCT04565496· Phase 2· Source

• Completed

  Artificial Intelligence & Prostate Cancer

  NCT06298305· Source

• Completed

  Immune Activation, Neural Plasticity and Depression

  NCT06306248· Source

• Completed

  Extension Study Evaluating The Safety And Tolerability of AMX0035

  NCT05619783· Phase 3· Source

• Completed

  Passive Music Listening in Acute Cerebrovascular Disease

  NCT06743412· Source

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· Source

• Completed

  A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

  NCT04968912· Phase 2· Source

• Completed

  MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)

  NCT04509791· Phase 2· Source

• Completed

  A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

  NCT04567602· Source

• Completed

  Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

  NCT04362072· Phase 4· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Source

• Completed

  A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis

  NCT04439526· Source

• Completed

  A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

  NCT04172675· Phase 2· Source

• Completed

  A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

  NCT04148911· Phase 3· Source

• Completed

  CIRSE Emprint Microwave Ablation Registry

  NCT03775980· Source

• Completed

  Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)

  NCT04034056· Source

• Completed

  Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

  NCT04212910· Source

• Completed

  Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression

  NCT05712967· Source

• Completed

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· Phase 3· Source

• Completed

  Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

  NCT03593590· Source

• Completed

  Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

  NCT02007512· Phase 2· Source